Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

XXII 22nd Century Group Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: XXII

Price (delayed)

$0.75

Market cap

$8.63M

P/E Ratio

0.04

Dividend/share

N/A

EPS

$17.93

Enterprise value

$13.06M

22nd Century is a plant biotechnology company focused on technology which allows it to decrease the level of nicotine in tobacco plants and modify the levels of cannabinoids in hemp/cannabis ...

Highlights
22nd Century Group's EPS has soared by 110% from the previous quarter and by 100% YoY
The net income has soared by 89% year-on-year and by 9% since the previous quarter
The company's equity has surged by 131% YoY but it fell by 10% QoQ
The company's quick ratio has surged by 57% YoY but it has shrunk by 50% QoQ
The revenue fell by 20% YoY and by 2.1% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.xxiicentury.com
Peers: PM MO

Key stats

What are the main financial stats of XXII
Market
Shares outstanding
11.51M
Market cap
$8.63M
Enterprise value
$13.06M
Valuations
Price to earnings (P/E)
0.04
Price to book (P/B)
0.49
Price to sales (P/S)
0.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.55
Earnings
Revenue
$23.87M
Gross profit
-$1.88M
Operating income
-$12.09M
Net income
-$13.75M
EBIT
-$12.09M
EBITDA
-$10.87M
Free cash flow
-$15.21M
Per share
EPS
$17.93
EPS diluted
$15.91
Free cash flow per share
-$8.8
Book value per share
$1.53
Revenue per share
$13.8
TBVPS
$8.87
Balance sheet
Total assets
$21.46M
Total liabilities
$17.83M
Debt
$5.56M
Equity
$3.63M
Working capital
-$5.3M
Liquidity
Debt to equity
1.53
Current ratio
0.68
Quick ratio
0.33
Net debt/EBITDA
-0.41
Margins
EBITDA margin
-45.5%
Gross margin
-7.9%
Net margin
-57.6%
Operating margin
-50.6%
Efficiency
Return on assets
-87.7%
Return on equity
-806.3%
Return on invested capital
-138.8%
Return on capital employed
-238.8%
Return on sales
-50.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

XXII stock price

How has the 22nd Century Group stock price performed over time
Intraday
-3.2%
1 week
-14.58%
1 month
-11.76%
1 year
-99.49%
YTD
-85.88%
QTD
-47.92%

Financial performance

How have 22nd Century Group's revenue and profit performed over time
Revenue
$23.87M
Gross profit
-$1.88M
Operating income
-$12.09M
Net income
-$13.75M
Gross margin
-7.9%
Net margin
-57.6%
The net income has soared by 89% year-on-year and by 9% since the previous quarter
The net margin has soared by 87% YoY and by 7% from the previous quarter
The gross profit has soared by 81% YoY and by 22% from the previous quarter
The company's gross margin has surged by 76% YoY and by 19% QoQ

Price vs fundamentals

How does XXII's price correlate with its fundamentals

Growth

What is 22nd Century Group's growth rate over time

Valuation

What is 22nd Century Group stock price valuation
P/E
0.04
P/B
0.49
P/S
0.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.55
22nd Century Group's EPS has soared by 110% from the previous quarter and by 100% YoY
The company's equity has surged by 131% YoY but it fell by 10% QoQ
The price to book (P/B) is 87% lower than the 5-year quarterly average of 3.7
The price to sales (P/S) is 99% lower than the 5-year quarterly average of 6.4 and 50% lower than the last 4 quarters average of 0.1
The revenue fell by 20% YoY and by 2.1% QoQ

Efficiency

How efficient is 22nd Century Group business performance
22nd Century Group's ROS has soared by 87% YoY and by 5% from the previous quarter
The ROIC has soared by 67% YoY but it has contracted by 7% from the previous quarter
The company's return on assets has surged by 63% YoY and by 17% QoQ
22nd Century Group's ROE has increased by 6% YoY

Dividends

What is XXII's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XXII.

Financial health

How did 22nd Century Group financials performed over time
22nd Century Group's total assets is 20% more than its total liabilities
The company's quick ratio has surged by 57% YoY but it has shrunk by 50% QoQ
The total liabilities has plunged by 51% YoY
The debt is 53% more than the equity
The company's equity has surged by 131% YoY but it fell by 10% QoQ
The debt has plunged by 66% YoY and by 35% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.